Liver transplant babies tracked for growth secrets
NCT ID NCT07574398
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study follows 275 infants who received a liver transplant to see how they grow over time. Researchers want to understand growth patterns and find ways to improve care. The study is observational, meaning no new treatment is being tested.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this could lead to better growth monitoring and tailored nutrition plans for children after liver transplant.
- What could go wrong
- This is an observational study, not testing a treatment. It may not directly improve outcomes, and results may not apply to all transplant centers.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 275 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Nov 2024
- Expected to finish
-
Dec 2029
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Children who underwent liver transplantation.
- Ages
-
Up to 1 year
- Sex
-
Anyone
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Children with end-stage liver disease of various etiologies requiring liver transplantation. * Approved by the ethics committee, and written informed consent has been obtained from the parents/legal guardians. * Age ≤ 1 year (infancy). Exclusion Criteria: * Age older than 1 year old. * Accept liver kidney combined transplantation surgery or second liver transplantation surgery.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for End-stage liver disease are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine
RECRUITINGShanghai, Shanghai Municipality, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can better training get doctors to talk about what matters most to dying veterans?
- Could a mask replace the breathing tube in liver transplants?
- Can immune cells predict herpesvirus danger in transplant patients?
- Muscle quality on MRI may foretell liver transplant success
- Better crystal ball for liver crisis: new scores put to the test
- A machine that keeps donor livers alive outside the body — could it transform transplantation?